Uri Ben‐David

Genetic and transcriptional evolution alters cancer cell line drug response

Uri Ben‐David, Benjamin A. Siranosian, Gavin Ha et al. · Nature · 2018 · 890 citations · Full text

Tumor Heterogeneity, Medicine, Oncogenic Agent +9

Discovering the anticancer potential of non-oncology drugs by systematic viability profiling

Steven M. Corsello, Rohith T. Nagari, Ryan D. Spangler et al. · Nature Cancer · 2020 · 831 citations · Full text

Tumor Biology, Systematic Viability Profiling, Medicine +12

Identification and Classification of Chromosomal Aberrations in Human Induced Pluripotent Stem Cells

Yoav Mayshar, Uri Ben‐David, Neta Lavon et al. · Cell stem cell · 2010 · 765 citations · Full text

Chromatin, Induced Pluripotent Stem Cell, Medicine +9

Patient-derived xenografts undergo mouse-specific tumor evolution

Uri Ben‐David, Gavin Ha, Yuen‐Yi Tseng et al. · Nature Genetics · 2017 · 703 citations · Full text

Lineage Plasticity, Xenotransplantation, Tumor Heterogeneity +4

Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting

Andrew J. Aguirre, Robin M. Meyers, Barbara A. Weir et al. · Cancer Discovery · 2016 · 598 citations · Full text